骁悉 (麦考酚酸酯 MMF)是一种新型的免疫抑制剂 ,在治疗血液病及自身免疫性疾病的报导较少 ,现就我们 1999年1月～ 2 0 0 0年 1月积累的 10例报告如下。1　临床资料1.1　一般资料　见表 1。 10例均为我院住院患者。诊断标准及疗效判断见参考文献 [1 ,2 ]。均为激素正规治疗无效 Xiao-Xi (mycophenolate mofetil MMF) is a new type of immunosuppressant, in the treatment of hematological and autoimmune diseases less reported, now we January 1999 ~ January 2000 accumulated 10 cases reported as follows. 1 clinical data 1.1 general information in Table 1. 10 cases were hospitalized patients in our hospital. Diagnostic criteria and efficacy judgment see references [1, 2]. Formal hormone therapy are invalid